Vinge has advised Triton Smaller Mid Cap Fund II in connection with the acquisition of Prenax from LBO France and certain minority shareholders.

Prenax is a leading subscriptions management service provider. The company was founded in 1993 and today manages the administration of over 340,000 subscriptions on behalf of its clients. Prenax has offices in 11 countries across the UK & Benelux, the Nordics, Southern Europe, the US, and Australia. 

The transaction is subject to regulatory approvals.

Vinge’s team mainly consisted of Johanna Wiberg, Egil Svensson, Michella Lina Said and Hedvig Merkel (M&A), David Olander and Lovisa Arpi (Regulatory), August Ahlin (Banking and Finance), Mario Saad and Jacob Eberil (Agreements), William Karo Persson (Employment), Carla Håkansson (IT), Siri Blomberg (GDPR), Arvid Axelryd and Melinda Oldenburg (IP), Simon Gille-Johnson (Real Estate), Hayaat Ibrahim (Compliance), Diana Kanold (Transaction Support Coordinator).

Read the client’s press release.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026